Clinical trial
Caffeinol Hypothermia Protocol
NCT00299416 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00299416 |
|---|---|
| Title | Caffeinol Hypothermia Protocol |
| Official title | Combined Neuroprotective Modalities Coupled With Thrombolysis in Acute Ischemic Stroke: A Pilot Study of Caffeinol and Mild Hypothermia |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Ischemic Stroke |
| Intervention type | Drug, Procedure |
| Interventions | Caffeinol, hypothermia |
| Enrollment | 30 |
| Start date | Feb 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Mar 6, 2006 |
| Last update posted | May 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: